| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Child Obesity Solution |
|
E-Articles - Child Obesity Solution
Come visit our website to learn about obesity. You'll discover many things like childhood obesity or o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product besity treatment that can help you successfully get obesity solution. You will understand the ins and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in uts, crucial steps to take, and how you can begin. The population of overweight adults has now reache lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. 1 billion, of which 300,000 are suffering from obesity. By far, WHO considers adolescent obesity to b here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e an epidemic of global proportion. This phenomenon has affected both developed and developing countri d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s. Obesity is considered as one of the major causes of hypertension, cardiovascular diseases, certain ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ype of cancer, and type 2 diabetes milletus. The changing diet patterns, inactive lifestyles and the a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi bsence of healthy recreational facilities in the community have been identified as the causes of adole nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically cent obesity. obesity is determined through measuring the body mass index of a person, which means th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t the weight in kilograms is divided by the square of height in meters (kg/m2). A person is considered ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi obese if the BMI reaches above 30 k/m2. If the BMI is more than 25k/m2 but below 30k/m2 the person is ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a already overweight. As BMI increases, the likelihood of acquiring health related risks conversely incr dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ase. If the population of adolescent obesity continues to balloon, it is expected that more adults wil cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin be suffering from the dreadful and debilitating health effects of obesity. Psychological and social tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen problems are likewise adverse effects of obesity, specifically adolescent obesity. Obese adults more o t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ten than not withdrew themselves from social groups for fear of ridicule. They developed a low self-es ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eem because being fat or obese is considered unattractive. They are often the source of jokes among th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eir peers. The longer they experience alienation from their age group the more they succumb to depress . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de on, which may pose another health problem. Being fat is not socially bad after all, but if this line o elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip thinking should be supported, many adults will be suffering from depression and other health problems tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The New Goo Review is Coming Right At You Who's Anti-Aging Program is Best?
|